Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK

BACKGROUND: Multi-cancer early detection (MCED) next-generation-sequencing blood tests represent a potential paradigm shift in screening. METHODS: We estimated the impact of screening in the US and UK. We used country-specific parameters for uptake, and test-specific sensitivity and false-positive r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackshaw, Allan, Cohen, Sarah S., Reichert, Heidi, Kansal, Anuraag R., Chung, Karen C., Ofman, Joshua J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575970/
https://www.ncbi.nlm.nih.gov/pubmed/34426664
http://dx.doi.org/10.1038/s41416-021-01498-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575970/
https://www.ncbi.nlm.nih.gov/pubmed/34426664
http://dx.doi.org/10.1038/s41416-021-01498-4

Ejemplares similares